Publications by authors named "Ditte Bjerre"

Claim this Profile
T
The impact of human CES1 genetic variation on enzyme activity assessed by ritalinic acid/methylphenidate ratios.
Claus Stage, Kim Dalhoff, Henrik Berg Rasmussen, Louise Schow Guski, Ragnar Thomsen, Ditte Bjerre

Basic Clin Pharmacol Toxicol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel approach for CES1 genotyping: integrating single nucleotide variants and structural variation.
Ditte Bjerre, Henrik Berg Rasmussen, The Indices Consortium

Pharmacogenomics· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pharmacokinetics of Enalapril in Relation to CES1 Genotype in Healthy Danish Volunteers.
Claus Stage, Gesche Jürgens, Louise Schow Guski, Ragnar Thomsen, Ditte Bjerre

Basic Clin Pharmacol Toxicol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reappraisal of the genetic diversity and pharmacogenetic assessment of CES1.
Laura Ferrero-Miliani, Ditte Bjerre, Claus Stage, Majbritt Busk Madsen, Gesche Jűrgens

Pharmacogenomics· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of CES1 genotypes on the pharmacokinetics of methylphenidate in healthy Danish subjects.
Claus Stage, Gesche Jürgens, Louise Schow Guski, Ragnar Thomsen, Ditte Bjerre

Br J Clin Pharmacol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel procedure with improved resolution and specificity for amplification and differentiation of variants of the gene encoding carboxylesterase 1.
Ditte Bjerre, Henrik B Rasmussen,

Pharmacogenet Genomics· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic Impact of Carboxylesterase 1 Gene Variants in Patients with Congestive Heart Failure Treated with Angiotensin-Converting Enzyme Inhibitors.
Karl Emil Nelveg-Kristensen, Peter Bie, Laura Ferrero, Ditte Bjerre, Niels E Bruun

PLoS One· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics.
Henrik Berg Rasmussen, Ditte Bjerre, Kristian Linnet, Gesche Jürgens, Kim Dalhoff

Pharmacogenomics· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linkage and whole genome sequencing identify a locus on 6q25-26 for formal thought disorder and implicate MEF2A regulation.
Johan Hilge Thygesen, Sine Katharina Zambach, Andrés Ingason, Pär Lundin, Thomas Hansen, Ditte Bjerre

Schizophr Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on Xie et al.: The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease.
Ditte Bjerre, Laura Ferrero, Majbritt Madsen, Peter R Hansen, Henrik B Rasmussen

Pharmacogenet Genomics· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Porcine Parkin: molecular cloning of PARK2 cDNA, expression analysis, and identification of a splicing variant.
Ditte Bjerre, Lone Bruhn Madsen, Christian Bendixen, Knud Larsen

Biochem Biophys Res Commun· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis